219 related articles for article (PubMed ID: 18248842)
21. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
22. [Luteinized unruptured follicle syndrome].
Sato K; Kitagawa H
Kango Gijutsu; 1985 Jan; 31(1):102-4. PubMed ID: 3844482
[No Abstract] [Full Text] [Related]
23. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy.
Orvieto R; Homburg R
Fertil Steril; 2009 Apr; 91(4 Suppl):1533-5. PubMed ID: 18990384
[TBL] [Abstract][Full Text] [Related]
24. Modest follicle-stimulating hormone elevations in younger women: warn but don't disqualify.
Toner JP
Fertil Steril; 2004 Jun; 81(6):1493-5; discussion 496-7. PubMed ID: 15193465
[TBL] [Abstract][Full Text] [Related]
25. Follicle-stimulating hormone isoforms are not useful as pretreatment predictors of outcome in in vitro fertilization: a pilot study.
Smeenk JM; Braat DD; Kremer JA; Sweep FC; Thomas CM
Fertil Steril; 2006 May; 85(5):1519-22. PubMed ID: 16579995
[TBL] [Abstract][Full Text] [Related]
26. Putative predictors of antibodies against follicle-stimulating hormone in female infertility: a study based on in vitro fertilization patients.
Haller K; Salumets A; Grigorova M; Talja I; Salur L; Béné MC; Laan M; Uibo R
Am J Reprod Immunol; 2007 Mar; 57(3):193-200. PubMed ID: 17295898
[TBL] [Abstract][Full Text] [Related]
27. [Gonadotrophin dose and ovarian response: relations to the clinical outcome of in vitro fertilization and embryo transfer].
Xiong XS; Chen SL; Sun L; Yin MN; Zhao EY; Song J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):712-4. PubMed ID: 18504186
[TBL] [Abstract][Full Text] [Related]
28. The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization.
Klinkert ER; Broekmans FJ; Looman CW; Habbema JD; te Velde ER
Fertil Steril; 2005 Mar; 83(3):811-4. PubMed ID: 15749527
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.
Kumbak B; Kahraman S
Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135
[TBL] [Abstract][Full Text] [Related]
30. [Luteinized unruptured follicle syndrome].
Zhu Q
Zhonghua Fu Chan Ke Za Zhi; 1989 Jan; 24(1):22-5, 58. PubMed ID: 2667911
[TBL] [Abstract][Full Text] [Related]
31. Antral follicle count is a significant predictor of livebirth in in vitro fertilization cycles.
Maseelall PB; Hernandez-Rey AE; Oh C; Maagdenberg T; McCulloh DH; McGovern PG
Fertil Steril; 2009 Apr; 91(4 Suppl):1595-7. PubMed ID: 19100533
[TBL] [Abstract][Full Text] [Related]
32. Luteinized unruptured follicle and IVF--significance?
Marik JJ
Fertil Steril; 1996 Nov; 66(5):858-9. PubMed ID: 8893703
[No Abstract] [Full Text] [Related]
33. Extensive excision of deep infiltrative endometriosis before in vitro fertilization significantly improves pregnancy rates.
Bianchi PH; Pereira RM; Zanatta A; Alegretti JR; Motta EL; Serafini PC
J Minim Invasive Gynecol; 2009; 16(2):174-80. PubMed ID: 19249705
[TBL] [Abstract][Full Text] [Related]
34. Understanding the physiology of folliculogenesis serves as the foundation for perfecting diagnosis and treatment of ovulatory defects.
Check JH
Clin Exp Obstet Gynecol; 2012; 39(3):273-9. PubMed ID: 23157023
[TBL] [Abstract][Full Text] [Related]
35. Mild ovarian stimulation for IVF.
Verberg MF; Macklon NS; Nargund G; Frydman R; Devroey P; Broekmans FJ; Fauser BC
Hum Reprod Update; 2009; 15(1):13-29. PubMed ID: 19091755
[TBL] [Abstract][Full Text] [Related]
36. [What advantages does treatment with highly purified FSH have in infertility?].
Breckwoldt M; Nieschlag E; Runnebaum B; Schneider HP
Zentralbl Gynakol; 1994; 116(1):56-7. PubMed ID: 8147183
[No Abstract] [Full Text] [Related]
37. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
[TBL] [Abstract][Full Text] [Related]
38. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.
Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Baart EB; Hohmann FP; Fauser BC; Broekmans FJ
Hum Reprod Update; 2009; 15(1):5-12. PubMed ID: 19091754
[TBL] [Abstract][Full Text] [Related]
39. In vitro fertilization in two patients with Kartagener's syndrome and infertility.
Abu-Musa A; Nassar A; Usta I
Gynecol Obstet Invest; 2008; 65(1):29-31. PubMed ID: 17671390
[TBL] [Abstract][Full Text] [Related]
40. [Polycystic ovary syndrome with infertility].
Mourali M; Fkih C; Essoussi-Chikhaoui J; Ben Hadj HA; Binous N; Ben Zineb N
Tunis Med; 2008 Nov; 86(11):963-72. PubMed ID: 19213486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
